total attack rate (%) |
8.45 (7.29–9.98) |
7.57 (6.63–8.36) |
6.93 (5.62–7.92) |
6.33 (4.86–7.45) |
clinical attack rate (%) |
5.17 (4.52–6.14) |
4.65 (4.08–5.06) |
4.22 (3.50–4.84) |
3.86 (2.97–4.61) |
asymptomatic attack rate (%) |
3.26 (2.78–3.83) |
2.94 (2.54–3.30) |
2.66 (2.12–3.09) |
2.47 (1.88–2.86) |
case fatality rate (%) |
1.40 (1.11–1.69) |
1.39 (1.14–1.81) |
1.39 (1.15–1.78) |
1.43 (1.01–1.73) |
infection fatality rate (%) |
0.85 (0.66–1.04) |
0.85 (0.70–1.10) |
0.85 (0.71–1.09) |
0.87 (0.62–1.06) |
number of shutdown days (from 8 Sep 2020 to 7 Jan 2022) |
211 (171–256) |
218 (185–256) |
229 (224–283) |
256 (211–283) |
total cases (clinical and asymptomatic) per 100 000 |
8461 (7298–9991) |
7580 (6633–8368) |
6933 (5623–7924) |
6334 (4864–7457) |
total clinical cases per 100 000 |
5180 (4528–6155) |
4652 (4081–5063) |
4227 (3499–4844) |
3867 (2976–4617) |
total asymptomatic cases per 100 000 |
3271 (2791–3836) |
2943 (2540–3305) |
2662 (2124–3090) |
2474 (1883–2863) |
total hospitalized cases (acute and ICU) per 100 000 |
520 (462–648) |
466 (391–538) |
431 (355–492) |
391 (297–468) |
total acute hospitalized cases per 100 000 |
383 (343–475) |
341 (288–412) |
317 (259–367) |
291 (219–348) |
total cases admitted into the ICU per 100 000 |
135 (115–168) |
117 (95–141) |
108 (80–133) |
95 (69–123) |
total deaths per 100 000 |
74 (57–90) |
65 (50–85) |
59 (40–74) |
53 (38–70) |
proportion of infections acquired at school (%) |
6.38 (5.31–7.75) |
6.32 (5.29–7.15) |
6.26 (5.17–7.31) |
6.09 (4.70–7.56) |
proportion of infections acquired at work (%) |
11.49 (10.42–12.30) |
11.47 (10.37–12.85) |
11.24 (10.05–12.39) |
11.28 (10.31–12.56) |
proportion of infections acquired in mixed-age venues (%) |
22.17 (21.03–23.49) |
21.95 (20.53–23.02) |
22.13 (20.97–23.33) |
21.97 (20.43–23.45) |
proportion of infections acquired in the household (%) |
60.12 (59.24–60.73) |
60.24 (59.26–61.10) |
60.48 (59.63–61.13) |
60.58 (59.80–61.44) |